# TOX High-Mobility Group Box Family Member 4 promotes DNA double-strand break repair via nonhomologous end joining

## TL;DR

TOX4 helps repair DNA breaks through a process called nonhomologous end joining, and its absence impairs DNA repair and could make cancer cells more vulnerable to treatment.

## Contribution

TOX4 is newly identified as a key factor in DNA repair via nonhomologous end joining by interacting with DNA-PK and phosphatase 1 nuclear-targeting subunit.

## Key findings

- TOX4 depletion leads to DNA damage accumulation and reduced nonhomologous end joining efficiency.
- TOX4 associates with DNA-PK and is required for DNA-PKcs activation.
- TOX4 coordinates with phosphatase 1 nuclear-targeting subunit to regulate DNA-PKcs phosphorylation.

## Abstract

Nonhomologous end joining (NHEJ) is a pivotal mechanism in the repair of DNA double-strand breaks. Central to NHEJ is the DNA-dependent protein kinase (DNA-PK) complex, comprising the KU heterodimer and the catalytic subunit, DNA-PKcs. In this study, we characterize Thymocyte Selection–Associated High-Mobility Group Box Family Member 4 (TOX4) as a factor recruited to both laser-induced DNA damage and endonuclease-induced DNA double-strand breaks. Depletion of TOX4 leads to accumulation of DNA damage, which is epistatic to DNA-PKcs. Consistently, TOX4 depletion substantially reduces NHEJ efficiency measured using both intrachromosomal and extrachromosomal repair assays. Our proteomic and biochemical analyses reveal TOX4 association with DNA-PK that is required for DNA-PKcs activation. Furthermore, we show that TOX4 coordinates with phosphatase 1 nuclear-targeting subunit in NHEJ. Phosphatase 1 nuclear-targeting subunit, previously shown to protect DNA-PKcs phosphorylation from protein phosphatase 1–mediated dephosphorylation, binds DNA-PK in a TOX4-dependent manner. In line with its role in DNA repair, TOX4 emerges as a promising target for anticancer drug development, and its targeting enhances tumor cell sensitivity to DNA damage in head and neck cancer and other malignancies.